S2531Referred to Committee

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-07-30
Introduced
3
Cosponsors
S
Type

Sponsor

Angela D. Alsobrooks
Angela D. Alsobrooks
Democrat · MD · Senator
Votes with party: 62.5% (320 recorded votes)

Full profile: /officials/A000382

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Committee Activity

Currently in

Previously

Plain-English Summary

This bill aims to improve treatment options and research funding for uterine fibroids, which are noncancerous tumors that affect millions of women and can cause severe pain and bleeding. The legislation would likely expand access to different surgical and non-surgical treatment choices for women dealing with fibroids and increase federal support for studying better ways to prevent and treat the condition. Women with fibroids, healthcare providers, and medical researchers would be the primary groups affected by these changes.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.